首页> 美国卫生研究院文献>PLoS Clinical Trials >The Added Value of Medical Testing in Underwriting Life Insurance
【2h】

The Added Value of Medical Testing in Underwriting Life Insurance

机译:医疗测试在承保人寿保险中的附加值

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundIn present-day life-insurance medical underwriting practice the risk assessment starts with a standard health declaration (SHD). Indication for additional medical screening depends predominantly on age and amount of insured capital. From a medical perspective it is questionable whether there is an association between the level of insured capital and medical risk in terms of mortality. The aim of the study is to examine the prognostic value of parameters from the health declaration and application form on extra mortality based on results from additional medical testing.
机译:背景技术在当今的人寿保险医疗承保业务中,风险评估始于标准的健康声明(SHD)。其他医疗检查的指示主要取决于年龄和被保险资产的数量。从医学的角度来看,在死亡率方面,是否存在被保险资本水平和医疗风险之间的关联性值得怀疑。该研究的目的是根据其他医学测试的结果,检查健康声明和申请表中参数对额外死亡率的预后价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号